Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PTC-607 by PTC Therapeutics for Huntington Disease: Likelihood of Approval
PTC-607 is under clinical development by PTC Therapeutics and currently in Phase I for Huntington Disease. According to GlobalData, Phase...